Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenylbutazone and anticoagulant control.

J Bull, J Mackinnon

    The Practitioner
    |December 1, 1975
    PubMed
    Summary

    Phenylbutazone and warfarin drug interaction can cause serious bleeding complications. Careful patient monitoring and dose adjustment can help avoid these dangerous hemorrhagic events.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Microbiome of the Eustachian tube in patients with chronic obstructive Eustachian tube dysfunction and healthy individuals.

    European journal of microbiology & immunology·2026
    Same author

    Lessons from the use of telemedicine in the austere military environment and the implications for deployed surgical teams.

    BMJ military health·2022
    Same author

    Preoperative sentinel lymph node identification, biopsy and localisation using contrast enhanced ultrasound (CEUS) in patients with breast cancer: a systematic review and meta-analysis.

    Clinical radiology·2017
    Same author

    Economic And Quality-Of-Life Burden Of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Spain: The Ibis-C Study.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
    Same author

    Diagnosis And Management Of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Spain: The Ibis-C Study.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
    Same author

    Racial/ethnic differences in drug disposition and response: review of recently approved drugs.

    Clinical pharmacology and therapeutics·2015

    Area of Science:

    • Pharmacology
    • Clinical Medicine
    • Drug Interactions

    Background:

    • Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID).
    • Warfarin is an anticoagulant medication used to prevent blood clots.
    • Both drugs are commonly prescribed, increasing the potential for interaction.

    Observation:

    • Three patients experienced severe bleeding complications.
    • These complications arose from the interaction between phenylbutazone and warfarin.
    • The interaction led to significant hemorrhagic events.

    Findings:

    • Concurrent use of phenylbutazone and warfarin poses a serious risk of hemorrhagic complications.
    • The interaction potentiates the anticoagulant effect of warfarin.
    • Detailed case reports highlight the severity of these adverse events.

    Implications:

    • Clinicians must be aware of the potential for severe bleeding when prescribing phenylbutazone with warfarin.
    • Close monitoring of prothrombin time (PT) and international normalized ratio (INR) is crucial.
    • Alternative pain management strategies should be considered in patients on warfarin therapy.

    Related Experiment Videos